|
1
|
Messerschmitt PJ, Garcia RM, Abdul-Karim
FW, Greenfield EM and Getty PJ: Osteosarcoma. J Am Acad Orthop
Surg. 17:515–527. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ottaviani G and Jaffe N: The etiology of
osteosarcoma. Cancer Treat Res. 152:15–32. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Allison DC, Carney SC, Ahlmann ER,
Hendifar A, Chawla S, Fedenko A, Angeles C and Menendez LR: A
meta-analysis of osteosarcoma outcomes in the modern medical era.
Sarcoma. 2012:7048722012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chou AJ and Gorlick R: Chemotherapy
resistance in osteosarcoma: Current challenges and future
directions. Expert Rev Anticancer Ther. 6:1075–1085. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Paoli P, Giannoni E and Chiarugi P:
Anoikis molecular pathways and its role in cancer progression.
Biochim Biophys Acta. 1833:3481–3498. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu L, McManus MM and Hughes DP:
Understanding the biology of bone sarcoma from early initiating
events through late events in metastasis and disease progression.
Front Oncol. 3:2302013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim YN, Koo KH, Sung JY, Yun UJ and Kim H:
Anoikis resistance: An essential prerequisite for tumor metastasis.
Int J Cell Biol. 2012:3068792012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guadamillas MC, Cerezo A and Del PMA:
Overcoming anoikis-pathways to anchorage-independent growth in
cancer. J Cell Sci. 124:3189–3197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mori S, Chang JT, Andrechek ER, Matsumura
N, Baba T, Yao G, Kim JW, Gatza M, Murphy S and Nevins JR:
Anchorage-independent cell growth signature identifies tumors with
metastatic potential. Oncogene. 28:2796–2805. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Strauss SJ, Ng T, Mendoza-Naranjo A,
Whelan J and Sorensen PH: Understanding micrometastatic disease and
Anoikis resistance in ewing family of tumors and osteosarcoma.
Oncologist. 15:627–635. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Giner F, Lopez-Guerrero JA, Machado I,
Garcia-Casado Z, Peydro-Olaya A and Llombart-Bosch A: The early
stages of tumor angiogenesis in human osteosarcoma: A nude mice
xenotransplant model. Virchows Arch. 467:193–201. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Walia A, Yang JF, Huang YH, Rosenblatt MI,
Chang JH and Azar DT: Endostatin's emerging roles in angiogenesis,
lymphangiogenesis, disease, and clinical applications. Biochim
Biophys Acta. 1850:2422–2438. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kerbel RS: Tumor angiogenesis: Past,
present and the near future. Carcinogenesis. 21:505–515. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matsumoto K and Ema M: Roles of VEGF-A
signalling in development, regeneration, and tumours. J Biochem.
156:1–10. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kaya M, Wada T, Akatsuka T, Kawaguchi S,
Nagoya S, Shindoh M, Higashino F, Mezawa F, Okada F and Ishii S:
Vascular endothelial growth factor expression in untreated
osteosarcoma is predictive of pulmonary metastasis and poor
prognosis. Clin Cancer Res. 6:572–577. 2000.PubMed/NCBI
|
|
16
|
Hu F, Shang XF, Wang W, Jiang W, Fang C,
Tan D and Zhou HC: High-level expression of periostin is
significantly correlated with tumour angiogenesis and poor
prognosis in osteosarcoma. Int J Exp Pathol. 97:86–92. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Q, Zhou Z, Shan L, Zeng H, Hua Y and
Cai Z: The importance of Src signaling in sarcoma. Oncol Lett.
10:17–22. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yeatman TJ: A renaissance for SRC. Nat Rev
Cancer. 4:470–480. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aleshin A and Finn RS: S RC A century of
science brought to the clinic. Neoplasia. 12:599–607. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanda S, Miyata Y, Kanetake H and
Smithgall TE: Non-receptor protein-tyrosine kinases as molecular
targets for antiangiogenic therapy (Review). Int J Mol Med.
20:113–121. 2007.PubMed/NCBI
|
|
21
|
Dai H, Lv YF, Yan GN, Meng G, Zhang X and
Guo QN: RanBP9/TSSC3 complex cooperates to suppress anoikis
resistance and metastasis via inhibiting Src-mediated Akt signaling
in osteosarcoma. Cell Death Dis. 7:e25722016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yan GN, Tang XF, Zhang XC, He T, Huang YS,
Zhang X, Meng G, Guo DY, Lv YF and Guo QN: TSSC3 represses
self-renewal of osteosarcoma stem cells and Nanog expression by
inhibiting the Src/Akt pathway. Oncotarget. 8:85628–85641. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao GS, Gao ZR, Zhang Q, Tang XF, Lv YF,
Zhang ZS, Zhang Y, Tan QL, Peng DB, Jiang DM, et al: TSSC3 promotes
autophagy via inactivating the Src-mediated PI3K/Akt/mTOR pathway
to suppress tumorigenesis and metastasis in osteosarcoma, and
predicts a favorable prognosis. J Exp Clin Cancer Res. 37:1882018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cui S, Wang J, Wu Q, Qian J, Yang C and Bo
P: Genistein inhibits the growth and regulates the migration and
invasion abilities of melanoma cells via the FAK/paxillin and MAPK
pathways. Oncotarget. 8:21674–21691. 2017.PubMed/NCBI
|
|
25
|
Huang D, Ding Y, Luo WM, Bender S, Qian
CN, Kort E, Zhang ZF, VandenBeldt K, Duesbery NS, Resau JH, et al:
Inhibition of MAPK kinase signaling pathways suppressed renal cell
carcinoma growth and angiogenesis in vivo. Cancer Res. 68:81–88.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, Meng G and Guo QN: Changes in
genomic imprinting and gene expression associated with
transformation in a model of human osteosarcoma. Exp Mol Pathol.
84:234–239. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsai HC, Tzeng HE, Huang CY, Huang YL,
Tsai CH, Wang SW, Wang PC, Chang AC, Fong YC and Tang CH: WISP-1
positively regulates angiogenesis by controlling VEGF-A expression
in human osteosarcoma. Cell Death Dis. 8:e27502017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Folkman J: Role of angiogenesis in tumor
growth and metastasis. Semin Oncol. 29:15–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mund JA and Case J: The role of
circulating endothelial progenitor cells in tumor angiogenesis.
Curr Stem Cell Res Ther. 6:115–121. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou W, Hao M, Du X, Chen K, Wang G and
Yang J: Advances in targeted therapy for osteosarcoma. Discov Med.
17:301–307. 2014.PubMed/NCBI
|
|
32
|
Zhang P, Chen L, Song Y, Li X, Sun Y, Xiao
Y and Xing Y: Tetraiodothyroacetic acid and transthyretin silencing
inhibit pro-metastatic effect of L-thyroxin in anoikis-resistant
prostate cancer cells through regulation of MAPK/ERK pathway. Exp
Cell Res. 347:350–359. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jain RK: Antiangiogenesis strategies
revisited: From starving tumors to alleviating hypoxia. Cancer
Cell. 26:605–622. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Frisch SM and Screaton RA: Anoikis
mechanisms. Curr Opin Cell Biol. 13:555–562. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Y, Ding C, Wang J, Sun G, Cao Y, Xu
L, Zhou L and Chen X: Prognostic significance of CD44V6 expression
in osteosarcoma: A meta-analysis. J Orthop Surg Res. 10:1872015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang Z, Luo C, Wang H, Yan X, Liu W and
Meng Z: CEACAM6 is associated with osteosarcoma metastasis and
facilitates epithelial-mesenchymal transition in osteosarcoma
cells. Onco Targets Ther. 11:3159–3166. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cantiani L, Manara MC, Zucchini C, De
Sanctis P, Zuntini M, Valvassori L, Serra M, Olivero M, Di Renzo
MF, Colombo MP, et al: Caveolin-1 reduces osteosarcoma metastases
by inhibiting c-Src activity and met signaling. Cancer Res.
67:7675–7685. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wan X, Kim SY, Guenther LM, Mendoza A,
Briggs J, Yeung C, Currier D, Zhang H, Mackall C, Li WJ, et al:
Beta4 integrin promotes osteosarcoma metastasis and interacts with
ezrin. Oncogene. 28:3401–3411. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Peng N, Gao S, Guo X, Wang G, Cheng C, Li
M and Liu K: Silencing of VEGF inhibits human osteosarcoma
angiogenesis and promotes cell apoptosis via VEGF/PI3K/AKT
signaling pathway. Am J Transl Res. 8:1005–1015. 2016.PubMed/NCBI
|
|
40
|
Carmeliet P and Jain RK: Molecular
mechanisms and clinical applications of angiogenesis. Nature.
473:298–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rak J, Mitsuhashi Y, Sheehan C, Krestow
JK, Florenes VA, Filmus J and Kerbel RS: Collateral expression of
proangiogenic and tumorigenic properties in intestinal epithelial
cell variants selected for resistance to anoikis. Neoplasia.
1:23–30. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Summy JM and Gallick GE: Src family
kinases in tumor progression and metastasis. Cancer Metastasis Rev.
22:337–358. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hu C, Deng Z, Zhang Y, Yan L, Cai L, Lei J
and Xie Y: The prognostic significance of Src and p-Src expression
in patients with osteosarcoma. Med Sci Monit. 21:638–645. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chandhanayingyong C, Kim Y, Staples JR,
Hahn C and Lee FY: MAPK/ERK signaling in osteosarcomas, Ewing
sarcomas and chondrosarcomas: Therapeutic implications and future
directions. Sarcoma. 2012:4048102012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Morrison DK: MAP kinase pathways. Cold
Spring Harb Perspect Biol. 4:a0112542012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Carduner L, Picot CR, Leroy-Dudal J, Blay
L, Kellouche S and Carreiras F: Cell cycle arrest or survival
signaling through alphav integrins, activation of PKC and ERK1/2
lead to anoikis resistance of ovarian cancer spheroids. Exp Cell
Res. 320:329–342. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Walsh MF, Thamilselvan V, Grotelueschen R,
Farhana L and Basson M: Absence of adhesion triggers differential
FAK and SAPKp38 signals in SW620 human colon cancer cells that may
inhibit adhesiveness and lead to cell death. Cell Physiol Biochem.
13:135–146. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Leelahavanichkul K, Amornphimoltham P,
Molinolo AA, Basile JR, Koontongkaew S and Gutkind JS: A role for
p38 MAPK in head and neck cancer cell growth and tumor-induced
angiogenesis and lymphangiogenesis. Mol Oncol. 8:105–118. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rodríguez-Berriguete G, Fraile B,
Martínez-Onsurbe P, Olmedilla G, Paniagua R and Royuela M: MAP
kinases and prostate cancer. J Signal Transduct.
2012:1691702012.PubMed/NCBI
|
